A computational model of inhibition of HIV-1 by interferon-alpha
Abstract
Type 1 interferons such as interferon-alpha (IFN) inhibit replication of Human immunodeficiency virus (HIV-1) by upregulating the expression of genes that interfere with specific steps in the viral life cycle. This pathway thus represents a potential target for immune-based therapies that can alter the dynamics of host-virus interactions to benefit the host. To obtain a deeper mechanistic understanding of how IFN impacts spreading HIV-1 infection, we modeled the interaction of HIV-1 with CD4 T cells and IFN as a dynamical system. This model was then tested using experimental data from a cell culture model of spreading HIV-1 infection. We found that a model in which IFN induces reversible cellular states that block both early and late stages of HIV-1 infection, combined with a saturating rate of conversion to these states, was able to successfully fit the experimental dataset. Sensitivity analysis showed that the potency of inhibition by IFN was particularly dependent on specific network parameters and rate constants. This model will be useful for designing new therapies targeting the IFN network in HIV-1-infected individuals, as well as potentially serving as a template for understanding the interaction of IFN with other viruses.\n\nAuthor SummaryInterferon-alpha (IFN) is a key component of the host response to HIV-1, but the details of how IFN regulates infection are still incompletely understood. To provide a deeper understanding of the dynamics of how IFN inhibits HIV-1, we simulated the interaction of IFN and HIV-1 as a computational model and compared this model to an experimental dataset. We identify a model structure that is able to fit many key features of the data. Furthermore, we use the model to predict optimal strategies for targeting the IFN pathway therapeutically. We anticipate that this model will be useful for further analysis of HIV-IFN interactions and will help to guide new therapeutic strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HIV-1 derived replication intermediates/oligonucleotides induce a type I IFN-dependent immune suppression via STING activation that can be restored by targeting IFNARI
Cecilia Svanberg, Ravi Prasad Mukku, … Marie Larsson·bioRxiv·Feb 17, 2025
- A combination of Interferon Stimulated Genes is more effective than IFNα and IFNss in reducing HIV-1 replication in human cervicovaginal tissues
C. Rollenhagen, J. Gui, … S. N. Asin·bioRxiv·Apr 16, 2019
- Restriction of HIV-1 infectivity by interferon and IFITM3 is counteracted by Nef
Mahesh Agarwal, Kin Kui Lai, … Alex A. Compton·Science AdvancesPeer-reviewed·Oct 1, 2025
- Differential Control of HIV-1 Replication by IFN-α14 Compared to IFN-α2 Relates to Differences in the Modulation of Host Antiretroviral Restriction Factors
Saurav Saswat Rout, Madeline T.E. Stewart, … Kerry J. Lavender·bioRxiv·Nov 1, 2025
- HIV infection does not alter Interferon α/β receptor expression on mucosal immune cells
J. Ickler, S. Francois, … K. Sutter·PLOS ONEPeer-reviewed·Jan 14, 2020
- Identification of Interleukin1β as an Amplifier of Interferon alpha-induced Antiviral Responses
Katharina Robichon, Tim Maiwald, … Ursula Klingmüller·PLoS PathogensPeer-reviewed·Oct 1, 2020